LASMIDITAN vs LECANEMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LASMIDITAN vs LECANEMAB: Safety Overview
| Metric | LASMIDITAN | LECANEMAB |
|---|---|---|
| Total FAERS Reports | 927 | 171 |
| Deaths Reported | 12 | 27 |
| Death Rate | 1.3% | 15.8% |
| Hospitalizations | 23 | 101 |
| Average Patient Age | 47.0 yrs | 74.2 yrs |
| % Female Patients | 85.4% | 64.1% |
| FDA Approval Date | Dec 18, 2020 | N/A |
| Manufacturer | Eli Lilly and Company | Eisai Inc. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | N/A |